The immune system's role in the biology of autism

Current Opinion in Neurology

Volumn 23, Issue 2, 2010, Pages 111-117

  Goines, Paula ^a,b   Van De Water, Judy ^a,b  

^a Division of Rheumatology Allergy and Clinical Immunology   (United States)

^b UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Autism; Autoantibodies; Cytokines; Immune system; Immunoglobulin

Indexed keywords

ANTINUCLEAR ANTIBODY; AUTOANTIBODY; BRAIN ANTIBODY; BRAIN PROTEIN; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G; IMMUNOGLOBULIN G4; IMMUNOGLOBULIN M; LEPTIN; MACROPHAGE MIGRATION INHIBITION FACTOR; MATERNAL ANTIBODY; MONOCYTE CHEMOTACTIC PROTEIN 1; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; POLYBROMINATED DIPHENYL ETHER; TOLL LIKE RECEPTOR; TRANSFORMING GROWTH FACTOR BETA;

ADIPOCYTE; ALLERGY; ANTIBODY SPECIFICITY; AUTISM; BEHAVIOR; BLOOD BRAIN BARRIER; BRAIN; BRAIN FUNCTION; CELLULAR IMMUNITY; CENTRAL NERVOUS SYSTEM; CHILD; DISEASE ASSOCIATION; FAMILY; GENE EXPRESSION; GENETIC POLYMORPHISM; GENETIC SUSCEPTIBILITY; GENOTYPE; HORMONE BLOOD LEVEL; HUMAN; IMMUNOBIOLOGY; IMMUNOGLOBULIN BLOOD LEVEL; IMMUNOHISTOCHEMISTRY; IMMUNOPATHOLOGY; INSULIN DEPENDENT DIABETES MELLITUS; LYMPHOCYTE SUBPOPULATION; MACROGLIA; MICROGLIA; MOLECULAR INTERACTION; MONOCYTE; NATURAL KILLER CELL; NEUROIMAGING; PATHOLOGY; PERIPHERAL BLOOD MONONUCLEAR CELL; PHENOTYPIC VARIATION; PLACENTAL TRANSFER; PRENATAL EXPOSURE; PRICK TEST; PROGENY; PROTEIN BLOOD LEVEL; PROTEIN CEREBROSPINAL FLUID LEVEL; PROTEIN TARGETING; REVIEW; RISK FACTOR; SENSITIZATION; SIBLING; SIGNAL TRANSDUCTION; SYSTEMIC LUPUS ERYTHEMATOSUS; ULCERATIVE COLITIS;

ANIMALS; AUTISTIC DISORDER; AUTOIMMUNITY; CHILD; HUMANS; HYPERSENSITIVITY; MODELS, NEUROLOGICAL;

EID: 77949343048     PISSN: 13507540     EISSN: None     Source Type: Journal    
DOI: 10.1097/WCO.0b013e3283373514     Document Type: Review

References (73)

1. Association AP. Diagnostic and statistical manual of mental disorders. Washington DC; 1994.
2. Ashwood P, Wills S, Van de Water J. The immune response in autism: a new frontier for autism research. J Leukoc Biol 2006; 80:1-15.
3. Enstrom AM, Van de Water JA, Ashwood P. Autoimmunity in autism. Curr Opin Investig Drugs 2009; 10:463-473.
4. Jyonouchi H, Sun S, Itokazu N. Innate immunity associated with inflammatory responses and cytokine production against common dietary proteins in patients with autism spectrum disorder. Neuropsychobiology 2002; 46: 76-84.
5. Jyonouchi H, Sun S, Le H. Proinflammatory and regulatory cytokine production associated with innate and adaptive immune responses in children with autism spectrum disorders and developmental regression. J Neuroimmunol 2001; 120 (1-2):170-179.
6. Gupta S, Aggarwal S, Rashanravan B, Lee T. Th1-and Th2-like cytokines in CD4+ and CD8+ T cells in autism. J Neuroimmunol 1998; 85:106-109.
7. Croonenberghs J, Bosmans E, Deboutte D, et al. Activation of the inflammatory response system in autism. Neuropsychobiology 2002; 45:1-6.
8. Molloy CA, Morrow AL, Meinzen-Derr J, et al. Elevated cytokine levels in children with autism spectrum disorder. J Neuroimmunol 2006; 172:198-205.
9. Bauer S, Kerr BJ, Patterson PH. The neuropoietic cytokine family in development, plasticity, disease and injury. Nat Rev Neurosci 2007; 8:221-232.
10. Okada K, Hashimoto K, IwataY, et al. Decreased serum levels of transforming growth factor-beta1 in patients with autism. Prog Neuropsychopharmacol Biol Psychiatry 2007; 31:187-190.
11. Ashwood P, Enstrom A, Krakowiak P, et al. Decreased transforming growth factor beta1 in autism: a potential link between immune dysregulation and impairment in clinical behavioral outcomes. J Neuroimmunol 2008; 204:149-153.
12. Vargas DL, Nascimbene C, Krishnan C, et al. Neuroglial activation and neuroinflammation in the brain of patients with autism. Ann Neurol 2005; 57:67-81.
13. Letterio JJ, Roberts AB. Regulation of immune responses by TGF-beta. Annu Rev Immunol 1998; 16:137-161.
14. Gomes FC, SousaVdeO, RomaoL. Emerging roles for TGF-beta 1 in nervous system development. Int J Dev Neurosci 2005; 23:413-424.
15. Grigorenko EL, Han SS, Yrigollen CM, et al. Macrophage migration inhibitory factor and autism spectrum disorders. Pediatrics 2008; 122:e438-e445.
16. Bacher M, Meinhardt A, Lan HY, et al. MIF expression in the rat brain: implications for neuronal function. Mol Med 1998; 4:217-230.
17. Fingerle-Rowson GR, Bucala R. Neuroendocrine properties of macrophage migration inhibitory factor (MIF). Immunol Cell Biol 2001; 79:368-375.
18. Ashwood P, Kwong C, Hansen R, et al. Brief report: plasma leptin levels are elevated in autism-association with early onset phenotype? J Autism Dev Disord 2008; 38:169-175.
19. Sanna V, Di Giacomo A, La Cava A, et al. Leptin surge precedes onset of autoimmune encephalomyelitis and correlates with development of pathogenic T cell responses. J Clin Invest 2003; 111:241-250.
20. Zhang Y, Proenca R, Maffei M, et al. Positional cloning of the mouse obese gene and its human homologue. Nature 1994; 372:425-432.
21. Banks WA. Leptin transport across the blood-brain barrier: implications for the cause and treatment of obesity. Curr Pharm Des 2001; 7:125-133.
22. Heuer L, Ashwood P, Schauer J, et al. Reduced levels of immunoglobulin in children with autism correlates with behavioral symptoms. Autism Res 2008; 1:275-283.
23. Enstrom A, Krakowiak P, OnoreC, et al. Increased IgG4 levels in children with autism disorder. Brain Behav Immun 2008; 23:389-395.
24. Perricone R, Perricone C, De Carolis C, Shoenfeld Y. NK cells in autoimmunity: a two-edged weapon of the immune system. Autoimmun Rev 2008; 7:384-390.
25. Gregg JP, Lit L, Baron CA, et al. Gene expression changes in children with autism. Genomics 2008; 91:22-29.
26. Vojdani A, Mumper E, Granpeesheh D, et al. Low natural killer cell cytotoxic activity in autism: the role of glutathione, IL-2 and IL-15. J Neuroimmunol 2008; 205:148-154.
27. Enstrom AM, Lit L, Onore CE, et al. Altered gene expression and function of peripheral blood natural killer cells in children with autism. Brain Behav Immun 2008; 23:123-133.
28. Czlonkowska A, Ciesielska A, GromadzkaG, Kurkowska-Jastrzebska I. Estrogen and cytokines production: the possible cause of gender differences in neurological diseases. Curr Pharm Des 2005; 11:1017-1030.
29. Lambertsen KL, Gregersen R, Meldgaard M, et al. A role for interferon-gamma in focal cerebral ischemia in mice. J Neuropathol Exp Neurol 2004; 63:942-955.
30. Gilmore JH, Jarskog LF, Vadlamudi S. Maternal poly I:C exposure during pregnancy regulates TNF alpha, BDNF, and NGF expression in neonatal brain and the maternal-fet al unit of the rat. J Neuroimmunol 2005; 159:106-112.
31. Enstrom AM, Onore CE, Van de Water JA, Ashwood P. Differential monocyte responses to TLR ligands in children with autism spectrum disorders. Brain Behav Immun 2010; 24:64-71.
32. Pardo CA, Vargas DL, Zimmerman AW. Immunity, neuroglia and neuroin flammation in autism. Int Rev Psychiatry 2005; 17:485-495.
33. Li X, Chauhan A, Sheikh AM, et al. Elevated immune response in the brain of autistic patients. J Neuroimmunol 2009; 207:111-116.
34. WHO. Brominated diphenyl ethers. Environmental Health Criteria, No. 162. Geneva: World Health Organization; 1994.
35. Johnson-Restrepo B, Kannan K. An assessment of sources and pathways of human exposure to polybrominated diphenyl ethers in the United States. Chemosphere 2009; 76:542-548.
36. Costa LG, Giordano G, Tagliaferri S, et al. Polybrominated diphenyl ether (PBDE) flame retardants: environmental contamination, human body burden and potential adverse health effects. Acta Biomed 2008; 79:172-183.
37. Lundgren M, Darnerud PO, Blomberg J, et al. Polybrominated diphenyl ether exposure suppresses cytokines important in the defence to coxsackievirus B3 infection in mice. Toxicol Lett 2009; 184:107-113.
38. Ashwood P, Schauer J, Pessah IN, de Water JV. Preliminary evidence of the in vitro effects of BDE-47 on innate immune responses in children with autism spectrum disorders. J Neuroimmunol 2009; 208 (1-2):130-135.
39. Menage P, Thibault G, Martineau J, et al. An IgE mechanism in autistic hypersensitivity? Biol Psychiatry 1992; 31:210-212.
40. Renzoni E, Beltrami V, Sestini P, et al. Brief report: allergological evaluation of children with autism. J Autism Dev Disord 1995; 25:327-333.
41. Bakkaloglu B, Anlar B, Anlar FY, et al. Atopic features in early childhood autism. Eur J Paediatr Neurol 2008; 12:476-479.
42. Zimmerman AW, Connors SL, Matteson KJ, et al. Maternal antibrain antibodies in autism. Brain Behav Immun 2007; 21:351-357.
43. Cabanlit M, Wills S, Goines P, et al. Brain-specific autoantibodies in the plasma of subjects with autistic spectrum disorder. Ann N Y Acad Sci 2007; 1107:92-103.
44. Wills S, Cabanlit M, Bennett J, et al. Detection of autoantibodies to neural cells of the cerebellum in the plasma of subjects with autism spectrum disorders. Brain Behav Immun 2009; 23:64-74.
45. Mostafa GA, Kitchener N. Serum antinuclear antibodies as a marker of autoimmunity in Egyptian autistic children. Pediatr Neurol 2009; 40:107-112.
46. Colasanti T, Delunardo F, Margutti P, et al. Autoantibodies involved in neuropsychiatric manifestations associated with systemic lupus erythemato-sus. J Neuroimmunol 2009; 212:3-9.
47. Diamond B, Kowal C, Huerta PT, et al. Immunity and acquired alterations in cognition and emotion: lessons from SLE. Adv Immunol 2006; 89:289-320.
48. Huerta PT, Kowal C, DeGiorgio LA, et al. Immunity and behavior: antibodies alter emotion. Proc Natl Acad Sci USA 2006; 103:678-683.
49. Kowal C, DeGiorgio LA, Nakaoka T, et al. Cognition and immunity: antibody impairs memory. Immunity 2004; 21:179-188.
50. Jones AL, Mowry BJ, Pender MP, Greer JM. Immune dysregulation and self-reactivity in schizophrenia: do some cases of schizophrenia have an autoimmune basis? Immunol Cell Biol 2005; 83:9-17.
51. Kiessling LS, Marcotte AC, Culpepper L. Antineuronal antibodies: tics and obsessive-compulsive symptoms. J Dev Behav Pediatr 1994; 15:421-425.
52. Pandey RS, Gupta AK, Chaturvedi UC. Autoimmune model of schizophrenia with special reference to antibrain antibodies. Biol Psychiatry 1981; 16:1123-1136.
53. Rothermundt M, Arolt V, Bayer TA. Review of immunological and immuno-pathological findings in schizophrenia. Brain Behav Immun 2001; 15:319-339.
54. Perrin EM, Murphy ML, Casey JR, et al. Does group A beta-hemolytic streptococcal infection increase risk for behavioral and neuropsychiatric symptoms in children? Arch Pediatr Adolesc Med 2004; 158:848-856.
55. Yeh CB, Wu CH, Tsung HC, et al. Antineural antibody in patients with Tourette's syndrome and their family members. J Biomed Sci 2006; 13:101-112.
56. Dalton KM, Nacewicz BM, Alexander AL, Davidson RJ. Gaze-fixation, brain activation, and amygdala volume in unaffected siblings of individuals with autism. Biol Psychiatry 2007; 61:512-520.
57. Kawakubo Y, Kuwabara H, Watanabe K, et al. Impaired prefrontal hemodynamic maturation in autism and unaffected siblings. PLoS One 2009; 4:e6881.
58. Saresella M, Marventano I, Guerini FR, et al. An autistic endophenotype results in complex immune dysfunction in healthy siblings of autistic children. Biol Psychiatry 2009; 66:978-984.
59. Braunschweig D, Ashwood P, Krakowiak P, et al. Autism: maternally derived antibodies specific for fet al brain proteins. Neurotoxicology 2008; 29:226-231.
60. Singer HS, Morris CM, Gause CD, et al. Antibodies against fet al brain in sera of mothers with autistic children. J Neuroimmunol 2008; 194:165-172.
61. Croen LA, Braunschweig D, Haapanen L, et al. Maternal mid-pregnancy autoantibodies to fet al brain protein: the early markers for autism study. Biol Psychiatry 2008; 64:583-588.
62. Simister NE. Placental transport of immunoglobulin G. Vaccine 2003; 21:3365-3369.
63. Heininger U, Desgrandchamps D, Schaad UB. Seroprevalence of varicella-zoster virus IgG antibodies in Swiss children during the first 16 months of age. Vaccine 2006; 24:3258-3260.
64. Djelmis J, Sostarko M, Mayer D, Ivanisevic M. Myasthenia gravis in pregnancy: report on 69 cases. Eur J Obstet Gynecol Reprod Biol 2002; 104:21-25.
65. MottaM, Rodriguez-Perez C, Tincani A, et al. Outcome of infants from mothers with anti-SSA/Ro antibodies. J Perinatol 2007; 27:278-283.
66. Morris CM, Zimmerman AW, Singer HS. Childhood serum antifet al brain antibodies do not predict autism. Pediatr Neurol 2009; 41:288-290.
67. Singer HS, Morris CM, Williams PN, et al. Antibrain antibodies in children with autism and their unaffected siblings. J Neuroimmunol 2006; 178:149-155.
68. Wills S, Cabanlit M, Bennett J, et al. Autoantibodies in autism spectrum disorders (ASD). Ann N Y Acad Sci 2007; 1107:79-91.
69. Lee JY, Huerta PT, Zhang J, et al. Neurotoxic autoantibodies mediate congenital cortical impairment of offspring in maternal lupus. Nat Med 2009; 15:91-96.
70. Martin LA, Ashwood P, Braunschweig D, et al. Stereotypies and hyperactivity in rhesus monkeys exposed to IgG from mothers of children with autism. Brain Behav Immun 2008; 22:806-816.
71. Mouridsen SE, Rich B, Isager T, Nedergaard NJ. Autoimmune diseases in parents of children with infantile autism: a case-control study. Dev Med Child Neurol 2007; 49:429-432.
72. Sweeten TL, Bowyer SL, Posey DJ, et al. Increased prevalence of familial autoimmunity in probands with pervasive developmental disorders. Pediatrics 2003; 112:e420.
73. Singer HS, Morris C, Gause C, et al. Prenatal exposure to antibodies from mothers of children with autism produces neurobehavioral alterations: a pregnant dam mouse model. J Neuroimmunol 2009; 211:39-48.